Optiver Holding’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $197 | Hold |
|
|||||
|
2025
Q2 | $177 | Hold |
|
|||||
|
2025
Q1 | $180 | Hold |
|
|||||
|
2024
Q4 | $187 | Sell |
|
|||||
|
2024
Q3 | $199K | Sell |
|
|||||
|
2024
Q2 | $169K | Buy |
|
|||||
|
2024
Q1 | $203K | Buy |
|
|||||
|
2023
Q4 | $63.6K | Sell |
|
|||||
|
2023
Q3 | $481K | Buy |
|
|||||
|
2023
Q2 | $257K | Sell |
|
|||||
|
2023
Q1 | $636K | Buy |
|
|||||
|
2022
Q4 | $394K | Sell |
|
|||||
|
2022
Q3 | $371K | Buy |
|
|||||
|
2022
Q2 | $491K | Buy |
|
|||||
|
2022
Q1 | $131K | Sell |
|
|||||
|
2021
Q4 | $1.03M | Buy |
|
|||||
|
2021
Q3 | $673K | Buy |
|
|||||
|
2021
Q2 | $15K | Sell |
|
|||||
|
2021
Q1 | $131K | Buy |
|